HSIL, High Grade Squamous Intraepithelial Lesion clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

    Sorry, not yet accepting patients

    This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population

    San Francisco, California and other locations

Last updated: